SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002236
Filing Date
2022-08-11
Accepted
2022-08-11 08:06:49
Documents
52
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220630x10q.htm   iXBRL 10-Q 1169991
2 EX-31.1 tmb-20220630xex31d1.htm EX-31.1 12168
3 EX-31.2 tmb-20220630xex31d2.htm EX-31.2 12194
4 EX-32.1 tmb-20220630xex32d1.htm EX-32.1 9740
  Complete submission text file 0001410578-22-002236.txt   4563046

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20220630.xsd EX-101.SCH 27575
6 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 41364
7 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 113050
8 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 307187
9 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 215382
46 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630x10q_htm.xml XML 738261
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 221153775
SIC: 2834 Pharmaceutical Preparations